1. Characterization of uncontrolled, severe asthma patients with type 2 inflammation (T2): results from a physician survey across countries from Latin American, Eurasian Middle East regions and China. (4th May 2022) Authors: Kosoy, Irina; Lew, Elisheva; Ledanois, Olivier; Derrickson, William Journal: Journal of asthma Issue: Volume 59:Number 5(2022) Page Start: 1021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical implications of prolonged hyperglycaemia before basal insulin initiation in type 2 diabetes patients: An electronic medical record database analysis. Issue 3 (28th March 2019) Authors: Raccah, Denis; Guerci, Bruno; Ajmera, Mayank; Davis, Keith; Meyers, Juliana; Lew, Elisheva; Shaunik, Alka; Blonde, Lawrence Journal: Endocrinology, diabetes & metabolism Issue: Volume 2:Issue 3(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluating drug cost per responder and number needed to treat associated with lixisenatide on top of glargine when compared to rapid-acting insulin intensification regimens on top of glargine, in patients with type 2 diabetes in the UK, Italy, and Spain. (3rd June 2017) Authors: Afonso, Marion; Ryan, Fay; Pitcher, Ashley; Lew, Elisheva Journal: Journal of medical economics Issue: Volume 20:Number 6(2017) Page Start: 633 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Evaluating glycaemic control in patients poorly controlled on oral antidiabetic drugs in real‐world setting: Results from assessing the Appropriate Timing of Type 2 diAbetes INtensification (ATTAIN). Issue 1 (29th September 2019) Authors: Jude, Edward B.; O'Leary, Caroline; Myland, Melissa; Nixon, Mark; Gooch, Nick; Shaunik, Alka; Lew, Elisheva Journal: Endocrinology, diabetes & metabolism Issue: Volume 3:Issue 1(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. IGlarLixi versus premixed insulin initiation in adults with type 2 diabetes advancing from basal insulin therapy: The SoliComplex real‐world study. Issue 5 (28th February 2023) Authors: Lajara, Rosemarie; Heller, Caroline; Pantalone, Kevin M.; Lew, Elisheva; Li, Xuan; Dex, Terry; Kilpatrick, Catherine Rachel Journal: Diabetes, obesity & metabolism Issue: Volume 25:Issue 5(2023) Page Start: 1249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impact of delaying treatment intensification with a glucagon‐like peptide‐1 receptor agonist in patients with type 2 diabetes uncontrolled on basal insulin: A longitudinal study of a US administrative claims database. Issue 4 (4th December 2017) Authors: Tong, Liyue; Pan, Chunshen; Wang, Hongwei; Bertolini, Monica; Lew, Elisheva; Meneghini, Luigi F. Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 4(2018) Page Start: 831 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Improved patient‐reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial. Issue 12 (23rd August 2022) Authors: Polonsky, William H.; Giorgino, Francesco; Rosenstock, Julio; Whitmire, Katherine; Lew, Elisheva; Coudert, Mathieu; Alvarez, Agustina; Nicholls, Charlie; McCrimmon, Rory J. Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 12(2022) Page Start: 2364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗